Immunomodulatory activities of whey β-lactoglobulin tryptic-digested fractions

International Dairy Journal

Volumn 34, Issue 1, 2014, Pages 65-73

  Rodríguez Carrio, Javier ^a   Fernández, Ayoa ^a   Riera, Francisco A ^a   Suárez, Ana ^a  

^a UNIVERSITY OF OVIEDO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE SECRETIONS; HUMAN IMMUNE SYSTEMS; HUMAN PERIPHERAL BLOOD; IMMUNOMODULATORY ACTIVITIES; INFLAMMATORY RESPONSE; MEMBRANE FILTRATIONS; MONOCYTE ACTIVATION; REGULATORY T CELLS;

MICROFILTRATION; PHYSIOLOGY;

PEPTIDES;

EID: 84883542204     PISSN: 09586946     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.idairyj.2013.07.004     Document Type: Article

References (36)

1. Antila P., Paakkari I., Järvinen A., Mattila M.J., Laukkanen M., Pihlanto-Leppälä A., et al. Opioid peptides derived from invitro proteolysis of bovine whey proteins. International Dairy Journal 1991, 1:215-229.
2. von Berg A., Filipiak-Pittroff B., Kramer U., Link E., Bollrath C., Brockow I., et al. Preventive effect of hydrolyzed infant formulas persists until age 6 years: long-term results from the German Infant Nutritional Intervention Study (GINI). Journal of Allergy and Clinical Immunology 2008, 121:1442-1447.
3. Bigelow C.C. On the average hydrophobicity of proteins and the relation between it and protein structure. Journal of Theoretical Biology 1967, 16:187-211.
4. Cross M.L., Gill H.S. Modulation of immune function by a modified bovine whey protein concentrate. Immunology and Cell Biology 1999, 77:345-350.
5. Elkord E. Novel therapeutic strategies by regulatory T cells in allergy. Chemical Immunology and Allergy 2008, 94:150-157.
6. Fernández A., Riera F. β-lactoglobulin tryptic-digestion: a model approach for peptide release. Biochemical Engineering Journal 2013, 70:88-96.
7. Fernández A., Suárez A., Zhu Y., FitzGerald R., Riera F. Membrane fractionation of a β-lactoglobulin tryptic digest: effect of the pH. Journal of Food Engineering 2013, 114:83-89.
8. Fritsche R., Pahud J.J., Pecquet S., Pfeifer A. Induction of systemic immunologic tolerance to β-lactoglobulin by oral administration of a whey protein hydrolysate. Journal of Allergy and Clinical Immunology 1997, 100:266-273.
9. Gattegno L., Migliore-Samour D., Saffar L., Jolles P. Enhancement of phagocytic activity of human monocytic-macrophagic cells by immunostimulating peptides from human casein. Immunology Letters 1988, 18:27-31.
10. Gauthier S.F., Pouliot Y., Saint-Sauveur D. Immunomodulatory peptides obtained by the enzymatic hydrolysis of whey proteins. International Dairy Journal 2006, 16:1315-1323.
11. Groleau P.E., Morin P., Gauthier S.F., Pouliot Y. Effect of physicochemical conditions on peptide-peptide interactions in a tryptic hydrolysate of β-lactoglobulin and identification of aggregating peptides. Journal of Agricultural and Food Chemistry 2003, 51:4370-4375.
12. Issazadeh-Navikas S., Teimer R., Bockermann R. Influence of dietary components on regulatory T cells. Molecular Medicine 2012, 18:95-110.
13. Kitts D.D., Weiler K. Bioactive proteins and peptides from food sources. Applications of bioprocesses used in isolation and recovery. Current Pharmaceutical Design 2003, 9:1309-1323.
14. Knipping K., van Esch B.C., van Ieperen-van Dijk A.G., van Hoffen E., van Baalen T., Knippels L.M.J., et al. Enzymatic treatment of whey proteins in cow's milk results in differential inhibition of IgE-mediated mast cell activation compared to T-cell activation. International Archives of Allergy and Immunology 2012, 159:263-270.
15. Kuipers B.J., Gruppen H. Prediction of molar extinction coefficients of proteins and peptides using UV absorption of the constituent amino acids at 214nm to enable quantitative reverse phase high-performance liquid chromatography-mass spectrometry analysis. Journal of Agricultural and Food Chemistry 2007, 55:5445-5451.
16. Li E.W., Mine Y. Immunoenhancing effects of bovine glycomacropeptide and its derivatives on the proliferative response and phagocytic activities of human macrophagelike cells, U937. Journal of Agricultural and Food Chemistry 2004, 52:2704-2708.
17. Madureira A.R., Tavares T., Gomes A.M., Pintado M.E., Malcata F.X. Invited review: physiological properties of bioactive peptides obtained from whey proteins. Journal of Dairy Science 2010, 93:437-455.
18. Mullally M.M., Meisel H., FitzGerald R.J. Identification of a novel angiotensin-I-converting enzyme inhibitory peptide corresponding to a tryptic fragment of bovine beta-lactoglobulin. FEBS Letters 1997, 402:99-101.
19. Muñoz-Tamayo R., de Groot J., Wierenga P.A., Gruppen H., Zwietering M.H., Sijtsma L. Modeling peptide formation during the hydrolysis of β-casein by Lactococcus lactis. Process Biochemistry 2012, 47:83-93.
20. von Mutius E., Fritzsch C., Weiland S., Roll G., Magnussen H. Prevalence of asthma and allergic disorders among children in united Germany: a descriptive comparison. British Medical Journal 1992, 305:1395-1399.
21. Nijnik A., Madera L., Ma S., Waldbrook M., Elliott M.R., Easton D.M., et al. Synthetic cationic peptide IDR-1002 provides protection against bacterial infections through chemokine induction and enhanced leukocyte recruitment. Journal of Immunology 2010, 184:2539-2550.
22. Pecquet S., Bovetto L., Maynard F., Fritsche R. Peptides obtained by tryptic hydrolysis of bovine beta-lactoglobulin induce specific oral tolerance in mice. Journal of Allergy and Clinical Immunology 2000, 105:514-521.
23. Pellegrini A., Dettling C., Thomas U., Hunziker P. Isolation and characterization of four bactericidal domains in the bovine β-lactoglobulin. Biochimica et Biophysica Acta 2001, 1526:131-140.
24. Pena-Ramos E.A., Xiong Y.L. Antioxidative activity of whey protein hydrolysates in a liposomal system. Journal of Dairy Science 2001, 84:2577-2583.
25. Pena O.M., Afacan N., Pistolic J., Chen C., Madera L., Falsafi R., et al. Synthetic cationic peptide IDR-1018 modulates human macrophage differentiation. PLoS One 2013, 8:e52449.
26. Pihlanto-Leppälä A., Korhonen H. Angiotensin I converting enzyme inhibitory peptides derived from bovine milk proteins. International Dairy Journal 1998, 8:325-331.
27. Pihlanto A., Korhonen H. Bioactive peptides and proteins. Advances in Food and Nutrition Research 2003, 47:175-276.
28. Prioult G., Pecquet S., Fliss I. Stimulation of interleukin-10 production by acidic β-lactoglobulin-derived peptides hydrolyzed with Lactobacillus paracasei NCC2461 peptidases. Clinical and Diagnostic Laboratory Immunology 2004, 11:266-271.
29. Riera F., Fernández A., Muro C. Cheese whey as a source of bioactive peptides: production, analysis, purification and animal and human trials. Whey: Types, compositions and health implications 2012, 1-52. Nova Science Publishers, New York, NY, USA. R. Mauro, G. Ortera (Eds.).
30. Saint-Sauveur D., Gauthier S.F., Boutin Y., Montoni A. Immunomodulating properties of a whey protein isolate, its enzymatic digest and peptide fractions. International Dairy Journal 2008, 18:260-270.
31. Saint-Sauveur D., Gauthier S., Boutin Y., Montoni A., Fliss I. Effect of feeding whey peptide fractions on the immune response in healthy and Escherichia coli infected mice. International Dairy Journal 2009, 19:537-544.
32. Scott M.G., Dullaghan E., Mookherjee N., Glavas N., Waldbrook M., Thompson A., et al. An anti-infective peptide that selectively modulates the innate immune response. Nature Biotechnology 2007, 25:465-472.
33. Smithers G.W. Whey and whey proteins - from 'gutter-to-gold'. International Dairy Journal 2007, 18:695-704.
34. Szajewska H., Horvath A. Meta-analysis of the evidence for a partially hydrolyzed 100% whey formula for the prevention of allergic diseases. Current Medical Research and Opinion 2010, 26:423-437.
35. + T-cell subsets. American Journal of Pathology 2012, 180:221-234.
36. Wieczorek M., Jenssen H., Kindrachuk J., Scott W.R., Elliott M., Hilpert K., et al. Structural studies of a peptide with immune modulating and direct antimicrobial activity. Chemistry and Biology 2010, 17:970-980.